A Multicenter evaluation of leprosy rapid test Fast ML Flow Hanseníase in Brazil
European Journal of Clinical Microbiology & Infectious Diseases · 2025
DOI: 10.1007/s10096-025-05071-2 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2025. Verfasst von Djairo Pastor Saavedra und 12 weiteren Autor:innen. Beteiligte Einrichtung: Rapid Test Development and Production Laboratory, Institute of Tropical Pathology and Public Health, Federal University of Goiás, LDPTR/IPTSP/UFG), G…. Hauptthemen laut MEDLINE: Leprosy, Mycobacterium leprae, Antibodies, Bacterial. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo a Pesquisa do Estado do Amazonas, National Health Fund.
Abstract (Originalsprache)
PURPOSE: Leprosy represents a public health concern; its diagnosis remains clinical. Recently, the Brazilian public health system/SUS incorporated the leprosy-specific IgM anti-PGL-I rapid test Fast ML Flow Hanseníase (MLFH/Bioclin, Brazil; originally ML Flow) to aid leprosy contacts surveillance and diagnosis. Anti-PGL-I antibody levels correlate with bacterial load. This multicenter study evaluated MLFH performance in confirmed leprosy cases from four Brazilian reference centers. METHODS: MLFH results were compared to anti-PGL-I ELISA, bacilloscopy/BI and analyzed in indeterminate/I, pure neuritic/PN and in Ridley Jopling/RJ categories (tuberculoid/TT, borderline-tuberculoid/BT, borderline/BB, borderline-lepromatous/BL, lepromatous/LL). Leprosy patients' serum samples (N = 158; 95 multibacillary/MB, 63 paucibacillary/PB) were evaluated. Additionally, 20 previously tested leprosy samples were distributed to each center to assess MLFH repeatability, inter-center and inter-operator reproducibility. RESULTS: Higher MLFH seropositivity (84.8%) compared to ELISA (60.8%; p < 0.001) and bacilloscopy (50.6%; p < 0.001), indicated moderate and fair agreement, respectively. Visual intensity readings (0 to 4 + range) from 20 samples showed excellent agreement (ICC: 0.954); test repeatability was 95.57%. Compared to ELISA and bacilloscopy, positivity difference was statistically significant (p < 0.05) in TT, BT, and I forms. Lower MLFH positivity was observed in indeterminate, BT and PN forms. CONCLUSION: The change in MLFH result criteria adopted by Bioclin/SUS considering faint test line (0.5) as positive (originally negative in ML Flow), increased MLFH sensitivity leading to higher seropositivity in MB and especially in PB, known as weak antibody producers. However, when screening asymptomatic leprosy contacts, this modified criterion may lead to reduced specificity since in endemic areas, anti-PGL-I positivity alone does not necessarily indicate active disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rapid Test Development and Production Laboratory, Institute of Tropical Pathology and Public Health, Federal University of Goiás, LDPTR/IPTSP/UFG), Goiânia, GO, 74605-050, Brazil.
- Innovation Hub in Point of Care Technologies, Federal University of Goiás -Merck S/a. Alliance, Goiânia, GO, 74690-900, Brazil.
- Institute of Tropical Medicine of Rio Grande Do Norte, Federal University of Rio Grande Do Norte, Natal, Rio Grande Do Norte, Brazil.
- Nursing School, Federal University of Goiás, Goiania, 74690-900, Brazil.
- Clinic's Hospital School of Medicine, Federal University of Uberlandia (UFU), Uberlândia, Brazil.
- Ambulatory of Leprosy, Division of Dermatology, Lauro de Souza Lima Institute, Bauru, São Paulo, Brazil.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo a Pesquisa do Estado do Amazonas
- National Health Fund
Zitieren
APA
Saavedra, D. P., Nobre, M. L., Guimarães, R. A., Fogaça, M. B. T., Goulart, I. M. B., Barreto, J. A., de Souza, V. N. B., Jeronimo, S. M. B., Amorim, F. M., da Silva, T. P., Pinheiro, R. O., Stefani, M. M. A., & Bührer-Sékula, S. (2025). A Multicenter evaluation of leprosy rapid test Fast ML Flow Hanseníase in Brazil. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-025-05071-2
Vancouver
Saavedra DP, Nobre ML, Guimarães RA, Fogaça MBT, Goulart IMB, Barreto JA, et al. A Multicenter evaluation of leprosy rapid test Fast ML Flow Hanseníase in Brazil. European Journal of Clinical Microbiology & Infectious Diseases. 2025. doi:10.1007/s10096-025-05071-2
BibTeX
@article{Saavedra2025,
author = {Saavedra, Djairo Pastor and Nobre, Maurício Lisboa and Guimarães, Rafael Alves and Fogaça, Matheus Bernardes Torres and Goulart, Isabela Maria Bernardes and Barreto, Jaison Antônio and de Souza, Vânia Nieto Brito and Jeronimo, Selma Maria Bezerra and Amorim, Francianne Medeiros and da Silva, Tatiana Pereira and Pinheiro, Roberta Olmo and Stefani, Mariane Martins de Araújo and Bührer-Sékula, Samira},
title = {A Multicenter evaluation of leprosy rapid test Fast ML Flow Hanseníase in Brazil},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2025},
doi = {10.1007/s10096-025-05071-2}
}
EUVIMED